BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12097482)

  • 1. Coincident elevation of cAMP and calcium influx by PACAP-27 synergistically regulates vasoactive intestinal polypeptide gene transcription through a novel PKA-independent signaling pathway.
    Hamelink C; Lee HW; Chen Y; Grimaldi M; Eiden LE
    J Neurosci; 2002 Jul; 22(13):5310-20. PubMed ID: 12097482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PACAP activates calcium influx-dependent and -independent pathways to couple met-enkephalin secretion and biosynthesis in chromaffin cells.
    Hahm SH; Hsu CM; Eiden LE
    J Mol Neurosci; 1998 Aug; 11(1):43-56. PubMed ID: 9826785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).
    Taupenot L; Mahata SK; Wu H; O'Connor DT
    J Clin Invest; 1998 Feb; 101(4):863-76. PubMed ID: 9466982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms.
    Xiao D; Chu MM; Lee EK; Lin HR; Wong AO
    Neuroendocrinology; 2002 Nov; 76(5):325-38. PubMed ID: 12457043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenylate cyclase-activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells through multiple signaling pathways and increased binding of pre-existing activator protein-1-like transcription factors.
    Turquier V; Yon L; Grumolato L; Alexandre D; Fournier A; Vaudry H; Anouar Y
    Mol Pharmacol; 2001 Jul; 60(1):42-52. PubMed ID: 11408599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary adenylate cyclase-activating polypeptide regulation of vasoactive intestinal polypeptide transcription requires Ca2+ influx and activation of the serine/threonine phosphatase calcineurin.
    Lee HW; Hahm SH; Hsu CM; Eiden LE
    J Neurochem; 1999 Oct; 73(4):1769-72. PubMed ID: 10501227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional and posttranscriptional control of tyrosine hydroxylase gene expression during persistent stimulation of pituitary adenylate cyclase-activating polypeptide receptors on PC12 cells: regulation by protein kinase A-dependent and protein kinase A-independent pathways.
    Corbitt J; Vivekananda J; Wang SS; Strong R
    J Neurochem; 1998 Aug; 71(2):478-86. PubMed ID: 9681437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of protein kinases in neuropeptide gene regulation by PACAP in chromaffin cells: a pharmacological and bioinformatic analysis.
    Hamelink C; Lee HW; Hsu CM; Eiden LE
    Ann N Y Acad Sci; 2002 Oct; 971():474-90. PubMed ID: 12438168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptides stimulate mitogen-activated protein kinase in the pituitary cell line GH4C1 by a 3',5'-cyclic adenosine monophosphate pathway.
    Le Péchon-Vallée C; Magalon K; Rasolonjanahary R; Enjalbert A; Gérard C
    Neuroendocrinology; 2000 Jul; 72(1):46-56. PubMed ID: 10940738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.
    Kim WK; Kan Y; Ganea D; Hart RP; Gozes I; Jonakait GM
    J Neurosci; 2000 May; 20(10):3622-30. PubMed ID: 10804204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenylate cyclase-activating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells.
    Suzuki A; Kotoyori J; Oiso Y; Kozawa O
    Cell Signal; 1994 Jan; 6(1):11-6. PubMed ID: 7912096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary adenylate cyclase-activating polypeptide induces a sustained increase in intracellular free Ca(2+) concentration and catechol amine release by activating Ca(2+) influx via receptor-stimulated Ca(2+) entry, independent of store-operated Ca(2+) channels, and voltage-dependent Ca(2+) channels in bovine adrenal medullary chromaffin cells.
    Morita K; Sakakibara A; Kitayama S; Kumagai K; Tanne K; Dohi T
    J Pharmacol Exp Ther; 2002 Sep; 302(3):972-82. PubMed ID: 12183654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal polypeptide- and pituitary adenylate cyclase activating polypeptide-mediated control of catecholamine release from chromaffin tissue in the rainbow trout, Oncorhynchus mykiss.
    Montpetit CJ; Perry SF
    J Endocrinol; 2000 Sep; 166(3):705-14. PubMed ID: 10974664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of intracellular Ca2+ elevation but not cyclic AMP in PACAP-induced p38 MAP kinase activation in PC12 cells.
    Sakai Y; Hashimoto H; Shintani N; Ichibori A; Tomimoto S; Tanaka K; Hirose M; Baba A
    Regul Pept; 2002 Nov; 109(1-3):149-53. PubMed ID: 12409227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. A novel VIP-independent action of PHI via MAP kinase.
    Lelièvre V; Pineau N; Du J; Wen CH; Nguyen T; Janet T; Muller JM; Waschek JA
    J Biol Chem; 1998 Jul; 273(31):19685-90. PubMed ID: 9677397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
    Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
    Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M; Ganea D
    J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenylate-cyclase activating polypeptide (PACAP) evokes long-lasting secretion and de novo biosynthesis of bovine adrenal medullary neuropeptides.
    Babinski K; Bodart V; Roy M; De Léan A; Ong H
    Neuropeptides; 1996 Dec; 30(6):572-82. PubMed ID: 9004256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1.
    Delgado M; Ganea D
    J Biol Chem; 2001 Jan; 276(1):369-80. PubMed ID: 11029467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.